Bill
HB 1755
Overview: HB 1755, "relative to the 340B discounted drug purchasing program", is scheduled to be introduced on January 7, 2026, and referred to the Health, Human Services and Elder
Overview: HB 1755, "relative to the 340B discounted drug purchasing program", is scheduled to be introduced on January 7, 2026, and referred to the Health, Human Services and Elderly Affairs committee.
Purpose and Intent: The bill aims to address issues related to the 340B discounted drug purchasing program, which requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices.
Key Provisions:
- Requires the state to monitor and enforce compliance with the 340B program
- Prohibits drug manufacturers from taking actions that limit the ability of covered entities to access 340B discounted drugs
- Establishes penalties for drug manufacturers that violate the 340B program requirements
Affected Parties and Impacts: The bill would primarily impact health care organizations and covered entities that participate in the 340B program, as well as drug manufacturers that are required to provide discounted drugs. It could help ensure that eligible entities can access the discounted drugs as intended, potentially improving patient access to affordable medications.
Procedural and Timeline Considerations: The bill is scheduled to be introduced on January 7, 2026, and referred to the Health, Human Services and Elderly Affairs committee. It will then go through the standard legislative process, including committee hearings and votes in both chambers.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
